Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel von Meerum Terwogt, Jetske M, ten Bokkel Huinink, Wim W, Schellens, Jan HM, Schot, Margaret, Mandjes, Ingrid AM, Zurlo, Maria G, Rocchetti, Marurizio, Rosing, Hilde, Koopman, Franciska J, Beijnen, Jos H

Volltext

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study von van Ramshorst, Mette S, van Werkhoven, Erik, Mandjes, Ingrid A.M, Schot, Margaret, Wesseling, Jelle, Vrancken Peeters, Marie-Jeanne T.F.D, Meerum Terwogt, Jetske M, Bos, Monique E.M, Oosterkamp, Hendrika M, Rodenhuis, Sjoerd, Linn, Sabine C, Sonke, Gabe S

Volltext

POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Horm... von Baird, Richard D, van Rossum, Annelot GJ, Oliveira, Mafalda, Beelen, Karin, Gao, Meiling, Schrier, Mariette, Mandjes, Ingrid AM, Garcia-Corbacho, Javier, Vallier, Anne-Laure, Dougall, Greig, van Werkhoven, Erik, Linossi, Constanza, Kumar, Sanjeev, van Tinteren, Harm, Callari, Maurizio, Beddowes, Emma, Perez-Garcia, José-Manuel, Rosing, Hilde, Platte, Else, Nederlof, Petra, Schot, Margaret, de Vries Schultink, Aurelia, Bernards, René, Saura, Cristina, Gallagher, William, Cortès, Javier, Caldas, Carlos, Linn, Sabine C

Volltext bestellen

Abstract OT2-15-01: COntinue the SaMe systemic therapy after local ablative therapy for Oligoprogression in metastatic breast cancer - the COSMO study von Almekinders, Cornelia AM, Steenbruggen, Tessa G, Mandjes, Ingrid A., Lopez-Yurda, Marta, Bos, Monique EMM, Wiersma, Terry G, Sonke, Gabe S.

Volltext